Animas Looks Forward To Continuous Glucose Monitoring As Market Crowds

Animas' hoped-for launch of the GlucoWatch G3 continuous blood glucose monitoring system in the first half of 2006 will depend upon resolution of issues cited in a February warning letter from FDA

More from Archive

More from Medtech Insight